You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 286 No. 10, September 12, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Suddenly, 64 Stem Cell Lines

Brian Vastag

JAMA. 2001;286:1163-1164.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Washington—After word of President George W. Bush's decision to allow federal funding for established embryonic stem cells leaked to the media early last month, one surprise was still left: at least 60 of the cell lines exist, Bush said on August 9. But less than a dozen had been announced, leading top researchers to question the newfound cells' viability and even their existence.

It turns out that behind the scenes, Lana Skirboll, PhD, director of science policy at the National Institutes of Health (NIH), was canvassing the world. "We looked far and wide," she said at a news conference the day after the president's announcement. Most of the newly disclosed lines originated at private companies, all of which were apparently better at keeping secrets than Bush's staff.


Six types of cells derived from undifferentiated embryonic stem cells—liver, heart muscle, nerve, pancreatic islet, bone, and blood cells—are included . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.